[Contribution of bioavailable testosterone assay for the diagnosis of androgen deficiency in elderly men]
- PMID: 12773947
[Contribution of bioavailable testosterone assay for the diagnosis of androgen deficiency in elderly men]
Abstract
With age, some men develop symptoms resembling hypogonadism. Several cross-sectional and longitudinal studies have shown a decrease in testosterone levels with ageing in men. This finding has equally been observed in elderly men in good health. Testosterone levels decline progressively as of the thirties, at a rate which remains constant throughout life. While total testosterone levels decrease, sex hormone binding globulin (SHBG) levels on the contrary increase with age, with the result that the levels of free and non-SHBG-bound testosterone (corresponding to the fraction which is bioavailable to target cells) decrease more abruptly than that of total testosterone. Higher LH levels, decreased testosterone response to hCG and less Leydig cells all indicate that ageing induces partial testicular failure. However, the gonadotropic function is also affected in ageing. The hypothalamus-pituitary becomes more sensitive to gonad steroid feedback, LH pulse amplitude decreases, and the LH response to GnRH is blunted compared to the situation in young men. Thus LH level is not a valid index of androgen deficiency in elderly males. None of the androgen-dependent functions (libido, erection, sense of well-being, muscle mass and strength, fat mass, bone mass, erythropoiesis, etc.) are under exclusively androgen control, and there is no elderly male symptom which is completely specific to androgen deficiency. Thus, in elderly men, when clinical symptoms might indicate androgen deficiency, biological confirmation is needed. An assay which is independent of SHBG fluctuations is mandatory. Bioavailable testosterone assay by ammonium sulfate precipitation seems to us to be the optimum method for diagnosing androgen deficiency: it gives a reliable measurement for the testosterone fraction available to target cells, is adapted to clinical practice, and provides results that can be directly compared with current reference values for healthy young men.
Similar articles
-
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.J Clin Endocrinol Metab. 2000 Sep;85(9):3276-82. doi: 10.1210/jcem.85.9.6825. J Clin Endocrinol Metab. 2000. PMID: 10999822 Clinical Trial.
-
The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate.J Clin Endocrinol Metab. 1987 Dec;65(6):1118-26. doi: 10.1210/jcem-65-6-1118. J Clin Endocrinol Metab. 1987. PMID: 3119649
-
Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.J Clin Endocrinol Metab. 1996 May;81(5):1821-6. doi: 10.1210/jcem.81.5.8626841. J Clin Endocrinol Metab. 1996. PMID: 8626841
-
Diagnosis of partial androgen deficiency in the aging male.Ann Endocrinol (Paris). 2003 Apr;64(2):109-14. Ann Endocrinol (Paris). 2003. PMID: 12773944 Review.
-
Hormonal cut-offs of partial androgen deficiency: a survey of androgen assays.J Endocrinol Invest. 2005;28(3 Suppl):28-31. J Endocrinol Invest. 2005. PMID: 16042357 Review.
Cited by
-
(18)F-FDG Uptake of Human Testis on PET/CT: Correlation with Age, Sex Hormones, and Vasectomy.Nucl Med Mol Imaging. 2011 Dec;45(4):291-8. doi: 10.1007/s13139-011-0108-6. Epub 2011 Oct 5. Nucl Med Mol Imaging. 2011. PMID: 24900020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous